STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Fortrea (Nasdaq: FTRE) announced on December 10, 2025 the grant of inducement restricted stock units (RSUs) to two newly hired employees. The award totals 245,000 RSUs granted on December 10, 2025.

The RSUs vest in three equal annual installments beginning December 10, 2026, subject to continuous employment through each vesting date, and are governed by the company’s Amended and Restated 2025 Inducement Award Plan and the applicable award agreements. The grants were made under Nasdaq Listing Rule 5635(c)(4) as inducements to employment.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Key Figures

RSU grant size 245,000 RSUs Inducement awards to two new employees on Dec 10, 2025
Vesting schedule 3 annual installments RSUs vest annually starting Dec 10, 2026
Number of employees 2 employees Recipients of inducement RSU awards

Market Reality Check

$15.14 Last Close
Volume Volume 1,407,723 is close to the 20-day average of 1,350,437 (relative volume 1.04x). normal
Technical Price $15.14 is trading above the 200-day MA at $8.10, indicating a pre-existing uptrend.

Peers on Argus

FTRE was up 5.21% while key peers showed mixed to negative moves, including MRVI at -4.60%, QURE at -3.17%, and EYPT at -2.62%, suggesting stock-specific strength rather than a sector-wide move.

Historical Context

Date Event Sentiment Move Catalyst
Dec 04 Strategic partnership Positive -0.7% Collaboration to align CDMO manufacturing with CRO clinical development for cell/gene therapies.
Nov 25 Conference participation Neutral +7.0% Management scheduled to present at Citi and Evercore healthcare investor conferences.
Nov 24 Debt tender offer Positive +9.6% Completion of $75.7M senior notes tender offer funded with cash on hand.
Nov 17 Leadership change Neutral -6.0% Appointment of new general counsel and chief compliance officer to lead legal strategy.
Nov 05 Earnings update Positive +23.2% Q3 2025 results with $701.3M revenue and raised full-year revenue and EBITDA guidance.
Pattern Detected

Recent positive corporate and financial news has often seen strong gains, but several strategic or personnel updates showed negative or contrary reactions, indicating mixed alignment between news tone and price moves.

Recent Company History

Over the last few months, Fortrea has reported multiple developments, including Q3 2025 results with raised full‑year guidance, a debt-reducing senior notes tender, and a new general counsel appointment. Conference participation and a recent cell and gene therapy collaboration highlighted strategic and commercial positioning. Price reactions ranged from -5.96% to +23.20%, showing that even operationally positive or strategic announcements sometimes coincided with negative or muted moves. Today’s inducement RSU grants fit into an ongoing pattern of equity-based compensation and governance-related updates.

Market Pulse Summary

This announcement details an inducement grant of 245,000 restricted stock units to two new employees under Nasdaq Listing Rule 5635(c)(4), vesting over three years from December 10, 2026. It continues Fortrea’s pattern of using equity-based awards for leadership and talent, as seen in prior Form 4 filings. In context of recent earnings, debt-tender activity, and strategic collaborations, investors may watch for further disclosures on equity compensation, governance changes, and follow-on operational milestones.

Key Terms

restricted stock units financial
"announced the granting of an inducement award of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
nasdaq listing rule 5635(c)(4) regulatory
"These awards follow Nasdaq Listing Rule 5635(c)(4) and are intended as an inducement"
NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.
inducement award plan financial
"subject to the terms and conditions of the Company’s Amended and Restated 2025 Inducement Award Plan"
An inducement award plan is a package of pay, often including stock options or restricted shares, granted to a new employee or executive to attract them to join a company — think of it like a signing bonus paid partly in company stock. Investors care because these awards increase compensation expense and can dilute existing shareholders’ ownership, affecting earnings per share and incentives that shape company strategy.

AI-generated analysis. Not financial advice.

DURHAM, N.C., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization, today announced the granting of an inducement award of restricted stock units (“RSUs”) on December 10, 2025, to two newly hired employees. The award consisted of 245,000 RSUs that vest in three equal annual installments starting December 10, 2026, subject to the employee’s continuous employment through the applicable vesting date. The RSUs are subject to the terms and conditions of the Company’s Amended and Restated 2025 Inducement Award Plan and the award agreements covering the grants. These awards follow Nasdaq Listing Rule 5635(c)(4) and are intended as an inducement material to the individual becoming a new employee of the Company.

About Fortrea

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter).

Fortrea Contacts:

Tracy Krumme (Investors) – 984-385-6707, Tracy.Krumme@fortrea.com
Sue Zaranek (Media) – 919-943-5422, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com


FAQ

What did Fortrea (FTRE) announce on December 10, 2025 about RSU grants?

Fortrea announced it granted 245,000 RSUs to two newly hired employees on December 10, 2025 as inducement awards.

How do the Fortrea (FTRE) inducement RSUs vest and when is the first vesting date?

The RSUs vest in three equal annual installments with the first vesting on December 10, 2026, subject to continuous employment.

Under which plan were Fortrea (FTRE) inducement awards granted?

The awards are subject to the company’s Amended and Restated 2025 Inducement Award Plan and the related award agreements.

Why were the RSUs granted under Nasdaq Listing Rule 5635(c)(4) for Fortrea (FTRE)?

The company granted the RSUs as inducement awards material to the individuals becoming new employees, consistent with Nasdaq Listing Rule 5635(c)(4).

How many employees received the Fortrea (FTRE) inducement RSU grants on December 10, 2025?

Two newly hired employees received the inducement RSU grants totaling 245,000 RSUs.
Fortrea Holdings

NASDAQ:FTRE

FTRE Rankings

FTRE Latest News

FTRE Latest SEC Filings

FTRE Stock Data

1.33B
91.87M
0.5%
111.46%
11.57%
Biotechnology
Services-medical Laboratories
Link
United States
DURHAM